B cell‐dependent subtypes and treatment‐based immune correlates to survival in stage 3 and 4 lung adenocarcinomas

B cell‐dependent subtypes and treatment‐based immune correlates to survival in stage 3 and 4 lung adenocarcinomas

Abstract Lung cancer is the leading cause of cancer‐related deaths worldwide. Surgery and chemoradiation are the standard of care in early stages of non‐small cell lung cancer (NSCLC), while immunotherapy is the standard of care in late‐stage NSCLC. The immune composition of the tumor microenvironme...

Full description

Bibliographic Details
Main Authors: Susan Raju Paul, Ivan Valiev, Skylar E. Korek, Vladimir Zyrin, Diana Shamsutdinova, Olga Gancharova, Alexander Zaitsev, Ekaterina Nuzhdina, Diane L. Davies, Ibiayi Dagogo‐Jack, Felix Frenkel, Jessica H. Brown, Joshua M. Hess, Sarah Viet, Jason L. Petersen, Cameron D. Wright, Harald C. Ott, Hugh G. Auchincloss, Ashok Muniappan, Toshihiro Shioda, Michael Lanuti, Christel M. Davis, Erik A. Ehli, Yin P. Hung, Mari Mino‐Kenudson, Maria Tsiper, Ann E. Sluder, Patrick M. Reeves, Nikita Kotlov, Alexander Bagaev, Ravshan Ataullakhanov, Mark C. Poznansky
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:FASEB BioAdvances
Subjects:
B cells
deconvolution
immunology
immunotherapy
NSCLC
TLS
Online Access:https://doi.org/10.1096/fba.2023-00009

Internet

https://doi.org/10.1096/fba.2023-00009

Similar Items